法爾勝(000890.SZ):實際控制人變更爲周江、鄧峯、劉禮華、黃翔
格隆匯7月29日丨法爾勝(000890.SZ)公佈,近日,江蘇法爾勝股份有限公司收到公司控股股東法爾勝泓昇集團有限公司(簡稱“泓昇集團”)通知,由於泓昇集團原股東繆勤女士已退休,其將持有的泓昇集團的全部股權轉讓給配偶劉禮華先生,轉讓後,劉禮華先生重新與周江先生、鄧峯先生、黃翔先生簽署《一致行動人協議書》。
本次權益變動屬於公司控股股東泓昇集團的股權結構變動,未導致泓昇集團持有的公司股份數量發生變化,不觸及對上市公司的要約收購,本次權益變動後,公司控股股東不變,仍爲泓昇集團,公司實際控制人由周江先生、鄧峯先生、繆勤女士、黃翔先生變更爲周江先生、鄧峯先生、劉禮華先生、黃翔先生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.